Coala Life Group AB
Coala-Life Group AB (publ) operates as a medical device company. The company develops medical innovations that enable long-term monitoring of patients in daily life, which supports diagnosis of heart and lungs and improve clinical outcomes. Its products offer healthcare providers diagnostic support by the ability to follow patient's in everyday life. The company offers Coala Heart Monitor, a medi… Read more
Coala Life Group AB (COALA) - Net Assets
Latest net assets as of August 2023: Skr40.40 Million SEK
Based on the latest financial reports, Coala Life Group AB (COALA) has net assets worth Skr40.40 Million SEK as of August 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr105.80 Million) and total liabilities (Skr65.40 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr40.40 Million |
| % of Total Assets | 38.19% |
| Annual Growth Rate | -5.17% |
| 5-Year Change | -89.9% |
| 10-Year Change | -90.81% |
| Growth Volatility | 100.64 |
Coala Life Group AB - Net Assets Trend (2003–2022)
This chart illustrates how Coala Life Group AB's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Coala Life Group AB (2003–2022)
The table below shows the annual net assets of Coala Life Group AB from 2003 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-08-31 | Skr39.33 Million | -24.85% |
| 2021-08-31 | Skr52.33 Million | +128.55% |
| 2020-08-31 | Skr22.90 Million | -90.26% |
| 2019-08-31 | Skr234.98 Million | -39.65% |
| 2018-08-31 | Skr389.36 Million | +14.52% |
| 2017-08-31 | Skr339.99 Million | +5.11% |
| 2016-08-31 | Skr323.46 Million | +5.81% |
| 2015-08-31 | Skr305.69 Million | +14.86% |
| 2014-08-31 | Skr266.14 Million | -37.78% |
| 2013-08-31 | Skr427.78 Million | -31.87% |
| 2012-08-31 | Skr627.88 Million | -34.55% |
| 2011-08-31 | Skr959.35 Million | -31.69% |
| 2010-08-31 | Skr1.40 Billion | +31.11% |
| 2009-08-31 | Skr1.07 Billion | -23.70% |
| 2008-08-31 | Skr1.40 Billion | -10.29% |
| 2007-08-31 | Skr1.57 Billion | +22.95% |
| 2006-08-31 | Skr1.27 Billion | +396.97% |
| 2005-08-31 | Skr256.15 Million | +95.91% |
| 2004-08-31 | Skr130.75 Million | +21.20% |
| 2003-08-31 | Skr107.88 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Coala Life Group AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 5679500000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (August 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr19.87 Million | 50.52% |
| Other Components | Skr144.84 Million | 368.29% |
| Total Equity | Skr39.33 Million | 100.00% |
Coala Life Group AB Competitors by Market Cap
The table below lists competitors of Coala Life Group AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
KON.VOPAK NV (VPK5.SG)
STU:VPK5
|
$469.16K |
|
Rising Stone S.A.
PA:ALRIS
|
$469.28K |
|
ONCIMMUNE HLDNGS LS-01
F:OCY
|
$469.69K |
|
Roth CH Acquisition V Co. Warrant
NASDAQ:ROCLW
|
$470.01K |
|
Quicklizard Ltd
TA:QLRD
|
$468.63K |
|
DLC Holdings Corp
V:DLC
|
$468.50K |
|
WisdomTree Voya Yield Enchanced USD Universal Bond Fund
NASDAQ:UNIY
|
$468.28K |
|
Santova Ltd
JSE:SNV
|
$467.85K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Coala Life Group AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 52,334,000 to 39,328,000, a change of -13,006,000 (-24.9%).
- Net loss of 141,923,000 reduced equity.
- New share issuances of 141,078,000 increased equity.
- Other factors decreased equity by 12,161,000.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-141.92 Million | -360.87% |
| Share Issuances | Skr141.08 Million | +358.72% |
| Other Changes | Skr-12.16 Million | -30.92% |
| Total Change | Skr- | -24.85% |
Book Value vs Market Value Analysis
This analysis compares Coala Life Group AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.04x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-08-31 | Skr1542.58 | Skr0.02 | x |
| 2004-08-31 | Skr1869.61 | Skr0.02 | x |
| 2005-08-31 | Skr3477.40 | Skr0.02 | x |
| 2006-08-31 | Skr14365.38 | Skr0.02 | x |
| 2007-08-31 | Skr16944.61 | Skr0.02 | x |
| 2008-08-31 | Skr15304.18 | Skr0.02 | x |
| 2009-08-31 | Skr6304.63 | Skr0.02 | x |
| 2010-08-31 | Skr5561.95 | Skr0.02 | x |
| 2011-08-31 | Skr3698.69 | Skr0.02 | x |
| 2012-08-31 | Skr2486.95 | Skr0.02 | x |
| 2013-08-31 | Skr879.92 | Skr0.02 | x |
| 2014-08-31 | Skr186.02 | Skr0.02 | x |
| 2015-08-31 | Skr213.66 | Skr0.02 | x |
| 2016-08-31 | Skr226.07 | Skr0.02 | x |
| 2017-08-31 | Skr237.63 | Skr0.02 | x |
| 2018-08-31 | Skr272.14 | Skr0.02 | x |
| 2019-08-31 | Skr165.53 | Skr0.02 | x |
| 2020-08-31 | Skr5.38 | Skr0.02 | x |
| 2021-08-31 | Skr5.74 | Skr0.02 | x |
| 2022-08-31 | Skr0.39 | Skr0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Coala Life Group AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -360.87%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -846.54%
- • Asset Turnover: 0.16x
- • Equity Multiplier: 2.68x
- Recent ROE (-360.87%) is below the historical average (-57.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | -41.84% | -5.25% | 2.07x | 3.85x | Skr-55.93 Million |
| 2004 | 17.49% | 2.75% | 2.36x | 2.69x | Skr9.80 Million |
| 2005 | 10.70% | 2.84% | 1.72x | 2.19x | Skr1.79 Million |
| 2006 | 0.92% | 0.74% | 0.54x | 2.32x | Skr-112.29 Million |
| 2007 | 16.40% | 7.35% | 1.16x | 1.93x | Skr99.54 Million |
| 2008 | 4.50% | 1.85% | 1.03x | 2.37x | Skr-77.19 Million |
| 2009 | 61.87% | 20.67% | 1.23x | 2.43x | Skr555.69 Million |
| 2010 | 2.06% | 0.95% | 1.21x | 1.79x | Skr-111.55 Million |
| 2011 | -46.40% | -15.01% | 1.43x | 2.17x | Skr-541.10 Million |
| 2012 | -52.39% | -11.78% | 1.55x | 2.87x | Skr-391.70 Million |
| 2013 | -146.97% | -24.00% | 2.01x | 3.04x | Skr-671.50 Million |
| 2014 | -60.50% | -8.40% | 1.86x | 3.87x | Skr-187.63 Million |
| 2015 | 13.84% | 1.98% | 1.99x | 3.52x | Skr11.72 Million |
| 2016 | 7.99% | 1.19% | 1.97x | 3.41x | Skr-6.49 Million |
| 2017 | 8.95% | 1.37% | 1.98x | 3.30x | Skr-3.57 Million |
| 2018 | 9.36% | 1.63% | 1.83x | 3.15x | Skr-2.49 Million |
| 2019 | -60.64% | -6.29% | 2.04x | 4.73x | Skr-165.98 Million |
| 2020 | -236.40% | -1612.03% | 0.10x | 1.49x | Skr-56.42 Million |
| 2021 | -287.99% | -3714.10% | 0.05x | 1.53x | Skr-155.95 Million |
| 2022 | -360.87% | -846.54% | 0.16x | 2.68x | Skr-145.86 Million |
Industry Comparison
This section compares Coala Life Group AB's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $77,740,696
- Average return on equity (ROE) among peers: -50.65%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Coala Life Group AB (COALA) | Skr40.40 Million | -41.84% | 1.62x | $468.93K |
| Acarix A/S (ACARIX) | $76.60 Million | -60.65% | 0.08x | $28.86 Million |
| Arcoma AB (ARCOMA) | $12.52 Million | -92.85% | 4.66x | $8.93 Million |
| Bactiguard Holding AB (publ) (BACTI-B) | $353.18 Million | -39.18% | 0.87x | $19.20 Million |
| CellaVision AB (CEVI) | $20.07 Million | 13.08% | 1.20x | $262.59 Million |
| Clinical Laserthermia Systems AB (publ) (CLS-B) | $65.69 Million | -72.50% | 0.20x | $13.78 Million |
| Chordate Medical Holding AB (CMH) | $38.95 Million | -55.88% | 0.13x | $17.64K |
| C-Rad AB (publ) (CRAD-B) | $93.64 Million | 22.63% | 0.57x | $56.67 Million |
| Duearity AB (DEAR) | $-2.39 Million | 0.00% | 0.00x | $34.43K |
| Episurf Medical AB (publ) (EPIS-B) | $41.40 Million | -170.53% | 0.39x | $5.40 Million |